🔎 Trials Near Me

Beranda › Glioma › Distrik Columbia › Washington

Uji klinis Glioma di Washington, DC

19 studi untuk Glioma mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Menerima pesertaFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07416188

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Menerima pesertaFase 2
  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

Menerima pesertaFase 1
  • Children's National Hospital, Washington D.C.
Usia 3 hingga 25 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07664176

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Menerima pesertaFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05588141

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Menerima pesertaFase 1
  • Children's National Medical Center, Washington D.C.
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT04485559

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06344130

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Menerima pesertaFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06161519

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Menerima pesertaFase 1/2
  • Children's National Hospital, Washington D.C.
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • Children's National Medical Center, Washington D.C.
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Menerima pesertaFase 1
  • Children's National Hospital, Washington D.C.
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT04573140

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Menerima pesertaFase 1/2
  • Sibley Memorial Hospital, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Menerima pesertaFase awal 1
  • Children's National Medical Center, Washington D.C.
Hingga usia 21 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04655404

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Menerima pesertaFase 1
  • National Institutes of Health, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT04541082

Uji klinis Glioma di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.